Cstone Pharma

Developing and licensing novel drugs for diseases including cancer and autoimmune diseases

placeShanghai, Shanghai, China calendar_todayFounded 2016 groups476 employees language cstonepharma.com

Social engagement

Social engagement: 8.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

16 investors on record; lead investors include Oriza Ventures, Boyu Capital, 6 Dimensions Capital, GIC; 2 have since exited.

Investor typeCountShare
Venture capital319%
Private equity744%
Other / undisclosed638%

Recent activity

25 Jun 2026
Partnership
Arrotex Pharmaceuticals
12 Jun 2026
Milestone
regulatory
1 Jun 2026
Milestone
regulatory
Coming soon